Maria K. Hristova-Kazmierski

Synthesis of [14C]Azodicarbonamide

J. Kepler, Maria K. Hristova-Kazmierski, 1999 .

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Susan M. Chang, S. Vandenberg, M. Prados, 2011, Neuro-oncology.

Synthesis of [12‐3H]‐(±)‐calanolide A

J. Kepler, Maria K. Hristova-Kazmierski, K. Rehder, 1996 .

Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

Martin Marciniak, David M Loesch, C. Obasaju, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.

Susan M. Chang, M. Prados, K. Lamborn, 2010, Neuro-oncology.

A new approach to enhance bioavailability of biologically active peptides: conjugation of a δ opioid agonist to β-cyclodextrin

R. Horváth, V. Hruby, H. Yamamura, 1993 .

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

G. Sledge, Menggang Yu, R. Zon, 2009, Investigational New Drugs.